Plasticity of mammary epithelia during normal development and neoplastic progression

Biochemistry and Cell Biology

Volumn 76, Issue 6, 1998, Pages 997-1008

  Lochter, André ^a  

^a CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

Author keywords

Branching morphogenesis; Cancer; Epithelial to mesenchymal transition; Lactogenic differentiation; Stem cells

Indexed keywords

BREAST CANCER; BREAST DEVELOPMENT; BREAST DUCT; BREAST EPITHELIUM; BREAST TUMOR; CELL DIFFERENTIATION; CELL REGENERATION; CELL RENEWAL; GENE MUTATION; HUMAN; MILK PRODUCTION; MYOEPITHELIUM CELL; NONHUMAN; PRECANCER; PREGNANCY; PUBERTY; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032321972     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o99-010     Document Type: Review

References (123)

1. Atherton, A.J., Monaghan, P., Warburton, M.J., Robertson, D., Kenny, A.J., and Gusterson, B.A. 1992. Dipeptidyl peptidase IV expression identifies a functional sub-population of breast fibroblasts. Int. J. Cancer. 50: 15-19.
2. Atherton, A.J., Warburton, M.J., O'Hare, M.J., Monaghan, P., Schuppan, D., and Gusterson, B.A. 1998. Differential expression of type XIV collagen/undulin by human mammary gland intralobular and interlobular fibroblasts. Cell Tissue Res. 291: 507-511.
3. Barcellos-Hoff, M.H., Aggeler, J., Ram, T.G., and Bissell, M.J. 1989. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development (Cambridge), 105: 223-235.
4. Barsky, S.H., Doberneck, S.A., Sternlicht, M.D., Grossman, D.A., and Love, S.M. 1997. 'Revertant' DCIS in human axillary breast carcinoma metastases. J. Pathol. 183: 188-194.
5. Bennett, D.C., Peachey, L.A., Durbin, H., and Rudland, P.S. 1978. A possible mammary stem cell line. Cell, 15: 283-298.
6. Berdichevsky, F., Alford, D., D'Souza, B., and Taylor-Papadimitriou, J. 1994. Branching morphogenesis of human mammary epithelial cells in collagen gels. J. Cell Sci. 107: 3557-3568.
7. Birchmeier, C., Birchmeier, W., and Brand-Saberi, B. 1996. Epithelial-mesenchymal transitions in cancer progression. Acta Anat. 156: 217-226.
8. Boudreau, N., Sympson, C.J., Werb, Z., and Bissell, M.J. 1995. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science (Washington, D.C.), 267: 891-893.
9. Boudreau, N., Werb, Z., and Bissell, M.J. 1996. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc. Natl. Acad. Sci. U.S.A. 93: 3509-3513.
10. Bussolati, G., Cassoni, P., Ghisolfi, G., Negro, F., and Sapino, A. 1996. Immunolocalization and gene expression of oxytocin receptors in carcinomas and non-neoplastic tissues of the breast. Am. J. Pathol. 148: 1895-1903.
11. Chepko, G., and Smith, G.H. 1997. Three division-competent, structurally distinct cell populations contribute to murine mammary epithelial renewal. Tissue Cell, 29: 239-253.
12. Cowley, G.P., and Smith, M.E. 1995. Modulation of E-cadherin expression and morphological phenotype in the intravascular component of adenocarcinomas. Int. J. Cancer. 60: 325-329.
13. Daams, H., Sonnenberg, A., Sakakura, T., and Hilgers, J. 1988. Changes in antigen patterns during development of the mouse mammary gland: implications for tumorigenesis. In Cellular and molecular biology of mammary cancer. Edited by D. Medina, W. Kidwell, G. Heppner, and E. Anderson. Plenum, New York. pp. 1-8.
14. Daniel, C.W., De Ome, K.B., Young, J.T., Blair, P.B., and Faulkin, L.J.J. 1968. The in vivo life span of normal and preneoplastic mouse mammary glands: a serial transplantation study. Proc. Natl. Acad. Sci. U.S.A. 61: 53-60.
15. Daniel, C.W., Berger, J.J., Strickland, P., and Garcia, R. 1984. Similar growth pattern of mouse mammary epithelium cultivated in collagen matrix in vivo and in vitro. Dev. Biol. 104: 57-64.
16. Darcy, K.M., Black, J.D., Hahm, H.A., and Ip, M.M. 1991. Mammary organoids from immature virgin rats undergo ductal and alveolar morphogenesis when grown within a reconstituted basement membrane. Exp. Cell Res. 196: 49-65.
17. De Leeuw, W.J., Berx, G., Vos, C.B., Peterse, J.L., Van de Vijver, M.J., Litvinov, S., van Roy, F., Cornelisse, C.J., and Cleton-Jansen, A.M. 1997. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J. Pathol. 183: 404-411.
18. Demicheli, R., Abbattista, A., Miceli, R., Valagussa, P., and Bonadonna, G. 1996. Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy. Breast Cancer Res. Treat. 41: 177-185.
19. Demicheli, R., Retsky, M.W., Swartzendruber, D.E., and Bonadonna, G. 1997. Proposal for a new model of breast cancer metastatic development. Ann. Oncol. 8: 1075-1080.
20. Domagala, W., Lasota, J., Dukowicz, A., Markiewski, M., Striker, G., Weber, K., and Osborn, M. 1990. Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas. Am. J. Pathol. 137: 1299-1304.
21. Dulbecco, R., Henahan, M., and Armstrong, B. 1982. Cell types and morphogenesis in the mammary gland. Proc. Natl. Acad. Sci. U.S.A. 79: 7346-7350.
22. Dulbecco, R., Unger, M., Armstrong, B., Bowman, M., and Syka, P. 1983. Epithelial cell types and their evolution in the rat mammary gland determined by immunological markers. Proc. Natl. Acad. Sci. U.S.A. 80: 1033-1037.
23. Dulbecco, R., Allen, W.R., Bologna, M., and Bowman, M. 1986a. Marker evolution during the development of the rat mammary gland: stem cells identified by markers and the role of myoepithelial cells. Cancer Res. 46: 2449-2456.
24. Dulbecco, R., Armstrong, B., Allen, W.R., and Bowman, M. 1986b. Distribution of developmental markers in rat mammary tumors induced by N-nitrosomethylurea. Cancer Res. 46: 5144-5152.
25. Emerman, J.T., and Pitelka, D.R. 1977. Maintenance and induction of morphological differentiation in dissociated mammary epithelium on floating collagen membranes. In Vitro, 13: 316-328.
26. Ferguson, D.J. 1985. Ultrastructural characterisation of the proliferative (stem?) cells within the parenchyma of the normal "resting" breast. Virchows Arch. A Pathol. Anat. Histopathol. 407: 379-385.
27. Ferguson, D.J. 1988. An ultrastructural study of mitosis and cytokinesis in normal 'resting' human breast. Cell Tissue Res. 252: 581-587.
28. Ferguson, D.J., and Anderson, T.J. 1981a. Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast. Br. J. Cancer. 44: 177-181.
29. Ferguson, D.J., and Anderson, T.J. 1981b. Ultrastructural observations on cell death by apoptosis in the "resting" human breast. Virchows Arch. Pathol. Anat. 393: 193-203.
30. Ferguson, J.E., Schor, A.M., Howell, A., and Ferguson, M.W. 1990. Tenascin distribution in the normal human breast is altered during the menstrual cycle and in carcinoma. Differentiation (Berlin), 42: 199-207.
31. Ferguson, J.E., Schor, A.M., Howell, A., and Ferguson, M.W. 1992. Changes in the extracellular matrix of the normal human breast during the menstrual cycle. Cell Tissue Res. 268: 167-177.
32. Foschini, M.P., Dina, R.E., and Eusebi, V. 1993. Sarcomatoid neoplasms of the breast: proposed definitions for biphasic and monophasic sarcomatoid mammary carcinomas. Semin. Diagn. Pathol. 10: 128-136.
33. Foster, C.S., Smith, C.A., Dinsdale, E.A., Monaghan, P., and Neville, A.M. 1983. Human mammary gland morphogenesis in vitro: the growth and differentiation of normal breast epithelium in collagen gel cultures defined by electron microscopy, monoclonal antibodies, and autoradiography. Dev. Biol. 96: 197-216.
34. Gilles, C., and Thompson, E.W. 1996. The epithelial to mesenchymal transition and metastatic progression in carcinoma. Breast, J. 2: 83-96.
35. Gompel, A., Martin, A., Simon, P., Schoevaert, D., Plu-Bureau, G., Hugol, D., Audouin, J., Leygue, E., Truc, J.B., and Poitout, P. 1996. Epidermal growth factor receptor and c-erbB-2 expression in normal breast tissue during the menstrual cycle. Breast Cancer Res. Treat. 38: 227-235.
36. Guarini, G., and Onofri, E. 1993. New horizons in medicine. Fractal. Recenti. Prog. Med. 84: 438-442.
37. Guarino, M., Tricomi, P., Giordano, F., and Cristofori, E. 1996. Sarcomatoid carcinomas: pathological and histopathogenetic considerations. Pathology, 28: 298-305.
38. Hager, J.C., Fligiel, S., Stanley, W., Richardson, A.M., and Heppner, G.H. 1981. Characterization of a variant-producing tumor cell line from a heterogeneous strain BALB/cfC3H mouse mammary tumor. Cancer Res. 41: 1293-1300.
39. Hahm, H.A., and Ip, M.M. 1990. Primary culture of normal rat mammary epithelial cells within a basement membrane matrix. I. Regulation of proliferation by hormones and growth factors. In Vitro Cell Dev. Biol. 26: 791-802.
40. Hahm, H.A., Ip, M.M., Darcy, K., Black, J.D., Shea, W.K., Forczek, S., Yoshimura, M., and Oka, T. 1990. Primary culture of normal rat mammary epithelial cells within a basement membrane matrix. II. Functional differentiation under serum-free conditions. In Vitro Cell Dev. Biol. 26: 803-814.
41. Harris, M. 1982. Spindle cell squamous carcinoma: ultrastructural observations. Histopathology, 6: 197-210.
42. Hay, E.D. 1995. An overview of epithelio-mesenchymal transformation. Acta Anat. 154: 8-20.
43. Hayward, S.W., Brody, J.R., and Cunha, G.R. 1996. An edgewise look at basal epithelial cells: three-dimensional views of the rat prostate, mammary gland and salivary gland. Differentiation (Berlin), 60: 219-227.
44. Heatley, M., Whiteside, C., Maxwell, P., and Toner, P. 1993. Vimentin expression in benign and malignant breast epithelium. J. Clin. Pathol. 46: 441-445.
45. Hendrix, M.J., Seftor, E.A., Chu, Y.W., Trevor, K.T., and Seftor, R.E. 1996. Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev. 15: 507-525.
46. Hendrix, M.J., Seftor, E.A., Seftor, R.E., and Trevor, K.T. 1997. Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am. J. Pathol. 150: 483-495.
47. Hirai, Y., Takebe, K., Takashina, M., Kobayashi, S., and Takeichi, M. 1992. Epimorphin: a mesenchymal protein essential for epithelial morphogenesis. Cell, 69: 471-481.
48. Hirai, Y., Lochter, A., Galosy, S., Koshida, S., Niwa, S., and Bissell, M.J. 1998. Epimorphin functions as a key morphoregulator for mammary epithelial cells. J. Cell Biol. 140: 159-169.
49. Hoshino, K. 1962. Morphogenesis and growth potential of mammary glands in mice. 1. Transplantability and growth potential of mammary tissue of virgin mice. Br. J. Cancer. 23: 835.
50. Hoshino, K. 1964. Regeneration and growth of quantitatively transplanted mammary glands of normal female mice. Anat. Rec. 150: 221.
51. Hughes, C.M., and Rudland, P.S. 1990. Appearance of myoepithelial cells in developing rat mammary glands identified with the lectins Griffonia simplicifolia-1 and pokeweed mitogen. J. Histochem. Cytochem. 38: 1647-1657.
52. Imagawa, W., Yang, J., Gazman, R., and Nandi, S. 1994. Control of mammary gland development. In The physiology of reproduction. Edited by B. Knobil and J. D. Neill. Raven Press, Ltd. New York. pp. 1033-1060.
53. Kato, M., Saunders, S., Nguyen, H., and Bernfield, M. 1995. Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol. Biol. Cell, 6: 559-576.
54. Klinowska, T.C., Broomhead, G., and Streuli, C.H. 1996. Requirement for bl integrins in the development of mouse mammary gland. Biochem. Soc. Trans. 24: 349S.
55. Kordon, E., and Smith, G. 1998. An entire functional mammary gland may comprise the progeny from a single cell. Development (Cambridge), 125: 1921-1930.
56. Kratochwil, K. 1969. Organ specificity in mesenchymal induction demonstrated in the embryonic development of the mammary gland of the mouse. Dev. Biol. 20: 46-71.
57. Lazard, D., Sastre, X., Frid, M.G., Glukhova, M.A., Thiery, J.P., and Koteliansky, V.E. 1993. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc. Natl. Acad. Sci. U.S.A. 90: 999-1003.
58. Li, M.L., Aggeler, J., Farson, D.A., Hatier, C., Hassell, J., and Bissell, M.J. 1987. Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 84: 136-140.
59. Lochter, A., and Bissell, M.J. 1995. Involvement of extracellular matrix constituents in breast cancer. Semin. Cancer Biol. 6: 165-173.
60. Lochter, A., Galosy, S., Muschler, J., Freedman, N., Werb, Z., and Bissell, M.J. 1997. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol. 139: 1861-1872.
61. Lochter, A., Sternlicht, M.D., Werb, Z., and Bissel, M.J. 1998. The significance of matrix metalloproteinases during early stages of tumor progression. Ann. N.Y. Acad. Sci. 857: 180-193.
62. MacDougall, J.R., and Matrisian, L.M. 1995. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev. 14: 351-362.
63. Matthay, M.A., Thiery, J.P., Lafont, F., Stampfer, F., and Boyer, B. 1993. Transient effect of epidermal growth factor on the motility of an immortalized mammary epithelial cell line. J. Cell. Sci. 106: 869-878.
64. Miettinen, P.J., Ebner, R., Lopez, A.R., and Derynck, R. 1994. TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J. Cell Biol. 127: 2021-2036.
65. Miller, F.R., and Heppner, G.H. 1979. Immunologic heterogeneity of tumor cell subpopulations from a single mouse mammary tumor. J. Natl. Cancer Inst. 63: 1457-1463.
66. Myers, C.A., Schmidhauser, C., Mellentin-Michelotti, J., Fragoso, G., Roskelley, C.D., Casperson, G., Mossi, R., Pujuguet, P., Hager, G., Bissell, M.J., and Bissel, M.J. 1998. Characterization of BCE-1, a transcriptional enhancer regulated by prolactin and extracellular matrix and modulated by the state of histone acetylation. Mol. Cell. Biol. 18: 2184-2195.
67. Nicoll, C.S., and Tucker, H.A. 1965. Estimates of parenchymal, stromal, and lymph node deoxyribonucleic acid in mammary glands of C3H/Crgl-2 mice. Life Sci. 4: 993-1001.
68. Niranjan, B., Buluwela, L., Yant, J., Perusinghe, N., Atherton, A., Phippard, D., Dale, T., Gusterson, B., and Kamalati, T. 1995. HGF/SF: a potent cytokine for mammary growth, morphogenesis and development. Development (Cambridge), 121: 2897-2908.
69. Oft, M., Peli, J., Rudaz, C., Schwarz, H., Beug, H., and Reichmann, E. 1996. TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 10: 2462-2477.
70. Olsson, H., Jernstrom, H., Alm, P., Kreipe, H., Ingvar, C., Jonsson, P.E., and Ryden, S. 1996. Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors. Breast Cancer Res. Treat. 40: 187-196.
71. Ormerod, E.J., and Rudland, P.S. 1984. Cellular composition and organization of ductal buds in developing rat mammary glands: evidence for morphological intermediates between epithelial and myoepithelial cells. Am. J. Anat. 170: 631-652.
72. Ormerod, E.J., and Rudland, P.S. 1986. Regeneration of mammary glands in vivo from isolated mammary ducts. J. Embryol. Exp. Morphol. 96: 229-243.
73. Ozzello, L. 1971. Ultrastructure of the human mammary gland. Pathol. Annu. 6: 1-59.
74. Pelham, H.R. 1993. Is epimorphin involved in vesicular transport? [see comments]. Cell, 73: 425-426.
75. Pitelka, D. 1977. The mammary gland. In Histology. Edited by I. Weiss and R.O. Green. New York, McGraw-Hill. pp. 925-950.
76. Price, J.E. 1990. The biology of metastatic breast cancer. Cancer (Amsterdam), 66: 1313-1320.
77. Reichmann, E., Ball, R., Groner, B., and Friis, R.R. 1989. New mammary epithelial and fibroblastic cell clones in coculture form structures competent to differentiate functionally. J. Cell Biol. 108: 1127-1138.
78. Rønnov-Jessen, L., Petersen, O.W., and Bissell, M.J. 1996. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev. 76: 69-125.
79. Roskelley, C.D., Srebrow, A., and Bissell, M.J. 1995. A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression. Curr. Opin. Cell Biol. 7: 736-747.
80. Rudland, P.S. 1987. Stem cells and the development of mammary cancers in experimental rats and in humans. Cancer Metastasis Rev. 6: 55-83.
81. Rudland, P.S. 1991. Histochemical organization and cellular composition of ductal buds in developing human breast: evidence of cytochemical intermediates between epithelial and myoepithelial cells. J. Histochem. Cytochem. 39: 1471-1484.
82. Rudland, P.S. 1993. Epithelial stem cells and their possible role in the development of the normal and diseased human breast. Histol. Histopathol. 8: 385-404.
83. Rudland, P.S., and Barraclough, R. 1988. Stem cells in mammary gland differentiation and cancer. J. Cell Sci. 10(Suppl.): 95-114.
84. Rudland, P.S., and Hughes, C.M. 1989. Immunocytochemical identification of cell types in human mammary gland: variations in cellular markers are dependent on glandular topography and differentiation. J. Histochem. Cytochem. 37: 1087-1100.
85. Rudland, P.S., Paterson, F.C., Monaghan, P., Davies, A.C., and Warburton, M.J. 1986. Isolation and properties of rat cell lines morphologically intermediate between cultured mammary epithelial and myoepithelial-like cells. Dev. Biol. 113: 388-405.
86. Rudland, P.S., Ollerhead, G., and Barraclough, R. 1989. Isolation of simian virus 40-transformed human mammary epithelial stem cell lines that can differentiate to myoepithelial-like cells in culture and in vivo. Dev. Biol. 136: 167-180.
87. Rudland, P.S., Leinster, S.J., Winstanley, J., Green, B., Atkinson, M., and Zakhour, H.D. 1993. Immunocytochemical identification of cell types in benign and malignant breast diseases: variations in cell markers accompany the malignant state. J. Histochem. Cytochem. 41: 543-553.
88. Russo, J., Rivera, R., and Russo, I.H. 1992. Influence of age and parity on the development of the human breast. Breast Cancer Res. Treat. 23: 211-218.
89. Sabourin, J.C., Martin, A., Baruch, J., Truc, J.B., Gompel, A., and Poitout, P. 1994. bcl-2 expression in normal breast tissue during the menstrual cycle. Int. J. Cancer, 59: 1-6.
90. Sakakura, T., Nishizuka, Y., and Dawe, C.J. 1976. Mesenchyme-dependent morphogenesis and epithelium-specific cytodifferentiation in mouse mammary gland. Science (Washington, D.C.), 194: 1439-1441.
91. Sakakura, T., Nishizuka, Y., and Dawe, C.J. 1979. Capacity of mammary fat pads of adult C3H/HeMs mice to interact morphogenetically with fetal mammary epithelium. J. Natl. Cancer Inst. 63: 733-736.
92. Sakakura, T., Kusano, I., Kusakabe, M., Inaguma, Y., and Nishizuka, Y. 1987. Biology of mammary fat pad in fetal mouse: capacity to support development of various fetal epithelia in vivo. Development (Cambridge), 100: 421-430.
93. Sapino, A., Macri, L., Gugliotta, P., Pacchioni, D., Liu, Y.J., Medina, D., and Bussolati, G. 1993. Immunophenotypic properties and estrogen dependency of budding cell structures in the developing mouse mammary gland. Differentiation (Berlin), 55: 13-18.
94. Schurch, W., Seemayer, T.A., and Lagace, R. 1981. Stromal myofibroblasts in primary invasive and metastatic carcinomas. A combined immunological, light and electron microscopic study. Virchows Arch. Pathol. Anat. 391: 125-139.
95. Seemayer, T.A., Lagace, R., Schurch, W., and Tremblay, G. 1979. Myofibroblasts in the stroma of invasive and metastatic carcinoma: a possible host response to neoplasia. Am. J. Surg. Pathol. 3: 525-533.
96. Smith, G.H. 1996. Experimental mammary epithelial morphogenesis in an in vivo model: evidence for distinct cellular progenitors of the ductal and lobular phenotype. Breast Cancer Res. Treat. 39: 21-31.
97. Smith, G.H., and Medina, D. 1988. A morphologically distinct candidate for an epithelial stem cell in mouse mammary gland. J. Cell Sci. 90: 173-183.
98. Sommers, C.L., Heckford, S.E., Skerker, J.M., Worland, P., Torri, J.A., Thompson, E.W., Byers, S.W., and Gelmann, E.P. 1992. Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines. Cancer Res. 52: 5190-5197.
99. Sonnenberg, A., Daams, H., Van der Valk, M.A., Hilkens, J., and Hilgers, J. 1986. Development of mouse mammary gland: identification of stages in differentiation of luminal and myoepithelial cells using monoclonal antibodies and polyvalent antiserum against keratin. J. Histochem. Cytochem. 34: 1037-1046.
100. Soriano, J.V., Pepper, M.S., Nakamura, T., Orci, L., and Montesano, R. 1995. Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. J. Cell Sci. 108: 413-430.
101. Stahl, S., Weitzman, S., and Jones, J.C. 1997. The role of laminin-5 and its receptors in mammary epithelial cell branching morphogenesis. J. Cell Sci. 110: 55-63.
102. Strange, R., Li, F., Friis, R.R., Reichmann, E., Haenni, B., and Burri, P.H. 1991. Mammary epithelial differentiation in vitro: minimum requirements for a functional response to hormonal stimulation. Cell Growth Diff. 2: 549-559.
103. Strange, R., Li, F., Saurer, S., Burkhardt, A., and Friis, R.R. 1992. Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development (Cambridge), 115: 49-58.
104. Streuli, C.H., Schmidhauser, C., Bailey, N., Yurchenco, P., Skubitz, A.P., Roskelley, C., and Bissell, M.J. 1995. Laminin mediates tissue-specific gene expression in mammary epithelia. J. Cell Biol. 129: 591-603.
105. Sympson, C.J., Talhouk, R.S., Alexander, C.M., Chin, J.R., Clift, S.M., Bissell, M.J., and Werb, Z. 1994. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell Biol. 125: 681-693.
106. Sympson, C.J., Bissell, M.J., and Werb, Z. 1995. Mammary gland tumor formation in transgenic mice overexpressing stromelysin-1. Semin. Cancer Biol. 6: 159-163.
107. Takeichi, M. 1993. Cadherins in cancer: implications for invasion and metastasis. Curr. Opin. Cell Biol. 5: 806-811.
108. Talhouk, R.S., Bissell, M.J., and Werb, Z. 1992. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J. Cell Biol. 118: 1271-1282.
109. Thomasset, N., Lochter, A., Sympson, C.J., Lund, L.R., Williams, D.R., Behrendtsen, O., Werb, Z., and Bissel, M.J. 1998. Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early involution. Am. J. Pathol. 153: 457-467.
110. Topper, Y.J., and Freeman, C.S. 1980. Multiple hormone interactions in the developmental biology of the mammary gland. Physiol. Rev. 60: 1049-1106.
111. Vleminckx, K., Vakaet, L.J., Mareel, M., Fiers, W., and van Roy, F. 1991. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66: 107-119.
112. Vogelstein, B., and Kinzler, K.W. 1993. The multistep nature of cancer. Trends Genet. 9: 138-141.
113. Warburton, M.J., Head, L.P., and Rudland, P.S. 1981. Redistribution of fibronectin and cytoskeletal proteins during the differentiation of rat mammary tumor cells in vitro. Exp. Cell Res. 132: 57-66.
114. Warburton, M.J., Ferns, S.A., and Rudland, P.S. 1982. Enhanced synthesis of basement membrane proteins during the differentiation of rat mammary tumour epithelial cells into myoepithelial-like cells in vitro. Exp. Cell Res. 137: 373-380.
115. Weaver, V.M., Howlett, A. R., Langton-Webster, B., Petersen, O. W., and Bissell, M. J. 1995. The development of a functionally relevant cell culture model of progressive human breast cancer. Semin. Cancer Biol. 6: 175-184.
116. Weaver, V.M., Petersen, O. W., Wang, F., Larabell, C. A., Briand, P., Damsky, C., and Bissell, M. J. 1997. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 137: 231-245.
117. Wellings, S.R., Jensen, H.M., and Marcum, R.G. 1975. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J. Natl. Cancer Inst. 55: 231-273.
118. Williams, J.M., and Daniel, C.W. 1983. Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. Dev. Biol. 97: 274-290.
119. Witty, J.P., Wright, J.H., and Matrisian, L.M. 1995. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol. Biol. Cell, 6: 1287-1303.
120. Wysolmerski, J.J., Philbrick, W.M., Dunbar, M.E., Lanske, B., Kronenberg, H., and Broadus, A.E. 1998. Rescue of the parathyroid hormone-related protein knockout mouse demonstrates that parathyroid hormone-related protein is essential for mammary gland development. Development (Cambridge), 125: 1285-1294.
121. Yang, Y., Spitzer, E., Meyer, D., Sachs, M., Niemann, C., Hartmann, G., Weidner, K.M., Birchmeier, C., and Birchmeier, W. 1995. Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J. Cell Biol. 131: 215-226.
122. Yant, J., Buluwela, L., Niranjan, B., Gusterson, B., and Kamalati, T. 1998. In vivo effects of hepatocyte growth Factor/Scatter factor on mouse mammary gland development. Exp. Cell Res. 241: 476-481.
123. Zschiesche, W., Schonborn, I., Behrens, J., Herrenknecht, K., Hartveit, F., Lilleng, P., and Birchmeier, W. 1997. Expression of E-cadherin and catenins in invasive mammary carcinomas. Anticancer Res. 17: 561-567.